GnRH: Clinical Trials

20 trials of GnRH, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 5 unknown, 2 active not recruiting, 2 terminated. 7 Phase 1, 7 Phase 2, 3 Phase 3, 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 17Completed 6, Terminated 1
Phase 27Completed 4, Unknown 3
Phase 33Recruiting 1, Terminated 1, Unknown 1
Not applicable2Active not recruiting 1, Completed 1
Phase 42Active not recruiting 1, Unknown 1

Follow GnRH: new trials by email Literature Review of GnRH trials Research Report on GnRH

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)
Follitropin alfa/lutropin alfa (MBJ-0011), hMG, Cetrorelix acetate - Infertility
Phase 3RecruitingMerck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany2662026-02-042026-09-08
Recall by Genotype: Neuropeptide Stimulation
kisspeptin 112-121, GnRH - Reproductive Disorder
Phase 1TerminatedStephanie B. Seminara, MD162023-10-202026-03-06
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
Testosterone, GnRH - Hypogonadism, Male, Testosterone Deficiency
UnknownRoyal College of Surgeons, Ireland602023-03-122023-03-17
Goserline Acetate VS Dienogest in Endometriosi
Zoladex, Visanne - Endometriosis
Phase 4UnknownMansoura University402020-12-252021-10-20
Conventional Androgen Deprivation Therapy (ADT) With or Without Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT
Prednisone, Apalutamide, Abiraterone Acetate - Prostate Cancer
Phase 3TerminatedDana-Farber Cancer Institute122020-04-202024-09-19
Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of Recurring
Gonadotrophin Releasing Hormone, Intensity-Modulated Radiation Therapy, Niraparib - Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8
Phase 1 / Phase 2CompletedNRG Oncology222019-10-082026-07-10
Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism
kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism
Phase 2CompletedStephanie B. Seminara, MD182019-05-032026-08-26
Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)
GnRH, Bicalutamide, Salvage radiation - Prostate Cancer
Phase 2UnknownDana-Farber Cancer Institute3452017-11-242024-05-14
Administration of Kisspeptin in Patients With Hyperprolactinemia
Kisspeptin 112-121, GnRH - Hyperprolactinemia, Hypogonadism
Phase 2CompletedMassachusetts General Hospital362017-11-172024-10-01
Reprometabolic Syndrome Mediates Subfertility in Obesity
Insulin, Intralipid, Dextrose - Obesity, Infertility
Not applicableActive not recruitingUniversity of Colorado, Denver842016-06-012026-03-02
GnRH for Luteal Support in IVF/ICSI/FET Cycles
GnRH, placebo - Infertility
Phase 4Active not recruitingUniversity Reproductive Associates3502015-11-012026-10-19
Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women
LOVAZA, GnRH - Obesity, Fertility
Not applicableCompletedUniversity of Colorado, Denver392014-07-012017-02-02
Neuropeptides in Human Reproduction
Kisspeptin 112-121, Naloxone, GnRH - Hypogonadotropic Hypogonadism
Phase 1CompletedMassachusetts General Hospital612014-04-302024-07-31
Kisspeptin in the Evaluation of Delayed Puberty
kisspeptin 112-121, GnRH - Delayed Puberty, Kallmann Syndrome
Phase 1CompletedMassachusetts General Hospital242013-06-082023-10-19
Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer
Cabazitaxel, Intensity Modulated Radiation Therapy (IMRT), Anti-Androgen Therapy: Bicalutamide - Prostate Cancer
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University202011-09-222025-05-15
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism, Healthy Postmenopausal Women
Phase 1CompletedMassachusetts General Hospital962011-09-012022-07-11
Kisspeptin Administration in the Adult
kisspeptin 112-121, GnRH - Hypogonadotropic Hypogonadism, Kallmann Syndrome
Phase 1CompletedMassachusetts General Hospital2562009-06-232024-07-31
The Effects of Aging and Estrogen on the Pituitary
GnRH, NAL-GLU GnRH antagonist, Estrogen patch - Healthy
Phase 2 / Phase 3UnknownMassachusetts General Hospital192002-01-012017-04-13
Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle
GnRH, Ketoconazole, Bicalutamide - Prostate, Cancer
Phase 2CompletedMemorial Sloan Kettering Cancer Center362001-07-012016-03-25
Pulsatile GnRH in Anovulatory Infertility
GnRH, Pump - Hypogonadotropic Hypogonadism, Amenorrhea
Phase 2UnknownMassachusetts General Hospital2701989-01-012017-07-12

Conditions studied

Hypogonadism (7)  ·  Infertility (5)  ·  Prostatic Neoplasms (5)  ·  Kallmann Syndrome (3)  ·  Obesity (3)  ·  Hyperprolactinemia (2)  ·  Amenorrhea (1)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus (1)  ·  Endometriosis (1)  ·  Eunuchism (1)  ·  Gonadal Dysgenesis (1)  ·  Hyperinsulinism (1)  ·  Metabolic Diseases (1)  ·  Metabolic Syndrome (1)

Sponsors

Massachusetts General Hospital (7)  ·  Dana-Farber Cancer Institute (2)  ·  Stephanie B. Seminara, MD (2)  ·  University of Colorado, Denver (2)  ·  Mansoura University (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1)  ·  NRG Oncology (1)  ·  Royal College of Surgeons, Ireland (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University Reproductive Associates (1)

Countries

United States (17)  ·  Canada (1)  ·  Egypt (1)  ·  Ireland (1)  ·  Japan (1)

Top investigators

Stephanie B Seminara, MD (5)  ·  Janet E Hall, M.D. (2)  ·  Alaa Mosbah (1)  ·  Alex Polotsky, MD, MS (1)  ·  Anthony D'Amico, MD, PhD (1)  ·  Howard Scher, MD (1)  ·  M. D Michaelson (1)  ·  Nanette Santoro, MD (1)  ·  Paul Nguyen, MD (1)  ·  Peter G McGovern, MD (1)  ·  Robert Den, MD (1)  ·  Stephanie Seminara (1)  ·  Stephanie Seminara, MD (1)

Results publications

PMID 29669934, PMID 31132118, PMID 19549740, PMID 20133465, PMID 23341491, PMID 25226293, PMID 26523525, PMID 28368443, PMID 30773100, PMID 32034419, PMID 32232399, PMID 33838870, PMID 38710978, PMID 39965102, PMID 41273106, PMID 42230485

NIH funding

P50HD104224 (1), R01AG013241 (1), U10CA180868 (1), U54HD028138 (1), U54HD058155 (1), UL1TR001082 (1)